BKYI
BKYI
NASDAQ · Technology

Bio-Key International Inc

$3.46
-1.85 (-34.84%)
As of May 16, 2:32 AM ET ·
Financial Highlights (FY 2026)
Revenue
44.84M
Net Income
-27,830,326
Gross Margin
81.4%
Profit Margin
-62.1%
Rev Growth
+10.7%
D/E Ratio
0.45
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 81.4% 81.4% 65.2% 65.2%
Operating Margin -57.9% -52.1% 13.3% 11.7%
Profit Margin -62.1% -59.0% 12.8% 12.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 44.84M 40.51M 2.41M 2.52M
Gross Profit 36.50M 32.97M 1.57M 1.64M
Operating Income -25,954,681 -21,103,273 321.6K 294.1K
Net Income -27,830,326 -22,628,325 309.8K 307.8K
Gross Margin 81.4% 81.4% 65.2% 65.2%
Operating Margin -57.9% -52.1% 13.3% 11.7%
Profit Margin -62.1% -59.0% 12.8% 12.2%
Rev Growth +10.7% +10.7% -0.5% +11.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 717.4K 717.4K 2.10M 2.56M
Total Equity 1.59M 1.59M 5.45M 4.87M
D/E Ratio 0.45 0.45 0.39 0.53
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -25,354,028 -21,760,164 436.8K 420.0K
Free Cash Flow 188.4K 244.3K